Initial approval rates for obesity medications sit around 35-40% across major Canadian insurers
In terms of reduction in glucose levels at 2 h after OGTT, 5 studies (with 205 and 213 subjects the experimental and control groups, respectively) were included for analysis
Consult with your healthcare provider before incorporating supplements into your care plan
Use of blood pressure and lipid-lowering medication, as well as prior and current tobacco use, is reported in Supplementary Table 5
The clinical pipeline represents diverse approaches to differentiation, including alternative receptor combinations, novel delivery mechanisms, and improved tolerability profiles
Track your progress with 'before and after' comparisons and utilize the measurement tracker to witness tangible results